Related Experiment Videos
Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis
Insights
Serum orosomucoid and erythrocyte sedimentation rate (ESR) effectively measure inflammatory activity in pediatric inflammatory bowel disease. Orosomucoid better reflects disease activity than ESR, offering complementary insights without added value from C-reactive protein (CRP).
Area of Science:
- Pediatric Gastroenterology
- Clinical Chemistry
- Inflammatory Bowel Disease (IBD)
Background:
- Assessing inflammatory activity in pediatric Crohn's disease and ulcerative colitis is crucial for effective management.
- Existing biomarkers like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have limitations in accurately reflecting disease status.
Purpose of the Study:
- To compare the efficacy of serum orosomucoid, ESR, and CRP in monitoring disease activity in children with Crohn's disease and ulcerative colitis.
- To determine if serum orosomucoid or ESR is a more reliable indicator of inflammatory activity and disease remission.
Main Methods:
- Blood samples were collected from pediatric patients diagnosed with Crohn's disease or ulcerative colitis.
- Laboratory tests including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and serum orosomucoid were performed.
- Results were correlated with clinical assessments of disease activity and remission status using regression analysis.
Main Results:
- Serum orosomucoid demonstrated a stronger correlation with disease activity compared to ESR in both pediatric Crohn's disease and ulcerative colitis.
- Serum orosomucoid, unlike ESR, could differentiate between remission and mild disease states in ulcerative colitis.
- No single biomarker consistently predicted the presence or absence of active disease.
- Orosomucoid and ESR provided complementary information, while CRP offered no additional diagnostic value.
- Corticosteroid medication did not interfere with the reliability of orosomucoid and ESR as inflammatory markers.
Conclusions:
- Serum orosomucoid is a valuable and potentially superior biomarker for assessing inflammatory activity in pediatric inflammatory bowel disease compared to ESR.
- Orosomucoid and ESR serve as complementary tools for monitoring disease activity, with CRP providing limited additional benefit.
- These biomarkers remain useful for evaluating inflammation even in patients undergoing corticosteroid treatment.
Abstract:
The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and serum orosomucoid were measured in children with Crohn's disease and ulcerative colitis in various states of disease activity. Results were matched with a clinical assessment to determine the correlation between laboratory test values and disease activity. Regression analysis showed that serum orosomucoid reflected disease activity better than ESR in both diseases. Orosomucoid but not ESR discriminated between disease in remission and mild disease in ulcerative colitis. No test invariably predicted presence or absence of active disease. Orosomucoid and ESR were complementary, but CRP was of no additional value. The usefulness of orosomucoid and ESR as objective measures of inflammatory activity was not masked by corticosteroid medication.